Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026. Keep ...
A 2025 report from a bipartisan, congressionally chartered commission warns that China is closing in on a win, and the United ...
From enabling more sustainable practices, to solving supply chain issues and inspiring creativity, here’s how biotech is ...
Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational ...
Provisions on research security, grant policies, indirect cost rates, and more are packed into the latest version of the NDAA ...
A recent breast cancer vaccine brings good news for women. The jab could help prevent Triple-negative breast cancer (TNBC) ...
These companies could innovate their way to success.
President Trump is shifting from discussion of the long-lasting competition among the world’s biggest economies and nuclear ...
The Slovak Spectator on MSN
Award-winning chemist: No need to fear chemistry
Chemist Michal Májek, who not long ago received another ERC grant for Slovakia, said that the country has a tradition of ...
This research led to Balu-Iyer founding the Buffalo-based company Immune Modulatory Therapies LLC in 2019. His UB co-founders ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback